SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
-----------------------
SCHEDULE 13G/A
(Rule 13d-102)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED
PURSUANT TO RULE 13d-2(b)
(Amendment No. 1) *
GENOMIC SOLUTIONS INC.
----------------------
(Name of Issuer)
COMMON STOCK, PAR VALUE $0.001 PER SHARE
----------------------------------------
(Title of Class of Securities)
37243R109
---------------
(CUSIP Number)
December 31, 2001
-----------------------
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
[ ] Rule 13d-1(b)
[ ] Rule 13d-1(c)
[X] Rule 13d-1(d)
------------------
* The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 (the "Act") or otherwise subject to the liabilities of that section
of the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
----------------------------- -----------------------------
CUSIP NO. 37243R109 PAGE 2 OF 5 PAGES
--------------------------------------------------------------------------------
1. NAMES OF REPORT PERSONS I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS
(ENTITIES ONLY)
PerkinElmer, Inc.
04-2052042
--------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ]
(b) [ ]
--------------------------------------------------------------------------------
3. SEC USE ONLY
--------------------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION
Massachusetts
--------------------------------------------------------------------------------
5. SOLE VOTING POWER
NUMBER OF 396,825
SHARES -------------------------------------------------------
BENEFICIALLY 6. SHARED VOTING POWER
OWNED BY
EACH 0
REPORTING -------------------------------------------------------
PERSON WITH 7. SOLE DISPOSITIVE POWER
396,825
-------------------------------------------------------
8. SHARED DISPOSITIVE POWER
0
--------------------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEIFICIALLY OWNED BY EACH REPORTING PERSON
396,825
--------------------------------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
[ ]
--------------------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
1.63%
--------------------------------------------------------------------------------
12. TYPE OF PERSON REPORTING*
CO
--------------------------------------------------------------------------------
CUSIP NO. 37243R109 PAGE 3 OF 5 PAGES
ITEM 1(a). NAME OF ISSUER:
Genomic Solutions Inc.
-------------------------------------------------------------------
ITEM 1(b). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES:
4355 Varsity Drive, Suite E, Ann Arbor, Michigan 48108
-------------------------------------------------------------------
ITEM 2(a). NAME OF PERSON FILING:
PerkinElmer, Inc.
-------------------------------------------------------------------
ITEM 2(b). ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE:
45 William Street, Wellesley, Massachusetts 02481
-------------------------------------------------------------------
ITEM 2(c). CITIZENSHIP OF PLACE OF ORGANIZATION:
Massachusetts
-------------------------------------------------------------------
ITEM 2(d). TITLE OF CLASS OF SECURITIES:
Common Stock
-------------------------------------------------------------------
ITEM 2(e). CUSIP NUMBER:
37243R109
-------------------------------------------------------------------
ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO RULE 13d-1(b), OR 13d-2(b)
OR (c), CHECK WHETHER THE PERSON FILING IS A:
Not Applicable
-------------------------------------------------------------------
ITEM 4. OWNERSHIP.
(a) Amount Beneficially Owned:
396,825
-------------------------------------------------------------------
(b) Percent of Class:
1.63%
-------------------------------------------------------------------
(c) Number of shares as to which such person has:
(i) Sole power to vote or direct the vote 396,824
-----------------------------
(ii) Shared power to vote or direct the vote 0
---------------------------
(iii) Sole power to dispose or to direct the disposition of 396,824
-------------
CUSIP NO. 37243R109 PAGE 4 OF 5 PAGES
(iv) Shared power to dispose or to direct the disposition of 0
------------
ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS.
If this statement is being filed to report the fact that as of the
date hereof the reporting person has ceased to be the beneficial
owner of more than five percent of the class of securities,
check the following [X].
ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON.
Not Applicable.
ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED
THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY OR
CONTROL PERSON.
Not Applicable.
ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP.
Not Applicable.
ITEM 9. NOTICE OF DISSOLUTION OF GROUP.
Not Applicable.
ITEM 10. CERTIFICATIONS.
Not Applicable.
CUSIP NO. 37243R109 PAGE 5 OF 5 PAGES
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
February 11, 2002
-------------------------------------
(Date)
PERKINELMER, INC.
By: /s/ John L. Healy
---------------------------------
Name: John L. Healy
Title: Associate General Counsel
and Assistant Clerk